Putting the award page together from the records…
Putting the award page together from the records…
CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)
Up for re-bid: ends 2026-10-31. Recompete brief → · NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
22 subawards totaling $143.69M (14368789969.0% of what was obligated), as Leidos Biomedical Research Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | $125.01M | 3 | NY | 2023-09-25 | 2024-11-01 |
| The Feinstein Institutes for Medical Research | $9.98M | 2 | NY | 2022-11-01 | 2023-09-14 |
| Mount Sinai Health System, Inc. | $3.35M | 2 | NY | 2022-11-01 | 2023-03-27 |
| American Type Culture Collection | $2.18M | 4 | VA | 2023-08-07 | 2024-09-12 |
| Essex Management LLC | $963.4K | 2 | MD, VT | 2023-08-24 | 2024-11-13 |
| Emory University | $797.3K | 1 | GA | 2023-11-30 | 2023-11-30 |
| Laboratory Corporation of America Holdings | $574.8K | 2 | MS | 2023-04-24 | 2023-07-10 |
| Information Management Services, Inc. | $351.7K | 3 | MD | 2023-09-28 | 2025-01-10 |
| Hamilton Company | $237.9K | 1 | NV | 2023-09-12 | 2023-09-12 |
| Fisher Scientific Company L.L.C. | $208.6K | 1 |
6 actions since 2023-02-06. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-03 | P00010 | Funding only | -$63.68M | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) |
| 2025-06-04 | P00009 | Terminated for convenience | $0 | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) |
| 2025-04-16 | P00008 | Terminated for convenience | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) |
| 2024-10-24 | P00007 | Administrative change | $0 | CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) |
| 2023-10-31 | P00006 | Administrative change | $0 | CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) |
| 2023-02-06 | P00005 | Administrative change | $0 | CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
| PA |
| 2024-10-11 |
| 2024-10-11 |
| Government Scientific Source Inc | $38.5K | 1 | VA | 2025-02-14 | 2025-02-14 |
| Date | To | Amount | For |
|---|---|---|---|
| 2024-03-29 | Icahn School of Medicine at Mount Sinai | $100.81M | THE OBJECTIVE OF THE FOLLOWING PUBLIC HEALTH INVESTIGATIONS IS TO DETERMINE THE ANTI-SARS-COV-2 ANTIBODY LEVELS AND SARS-COV-2 TOTAL NEUTRALIZING ANTIBODY PREVIOUSLY EXPOSED TO SARS-COV-2 AND/OR VACCINATED WITH CURRENT… |
| 2024-11-01 | Icahn School of Medicine at Mount Sinai | $13.10M | SUBCONTRACTOR SHALL CONTINUE TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING AND RESEARCH THROUGH INVESTIGATION OF CHARACTERISTICS OF THE IMMUNE RESPONSE THAT CORRELATE WITH PROTECTION FROM INFECTION OR SEVERE… |
| 2023-09-25 | Icahn School of Medicine at Mount Sinai | $11.10M | SUBCONTRACTOR SHALL CONTINUE TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING THROUGH 1) ASSAY DEVELOPMENT 2) LARGE SCALE TESTING FOR ANALYSIS OF SERONET SAMPLES 3) INVESTIGATE CHARACTERISTICS OF THE IMMUNE… |
| 2023-09-14 | The Feinstein Institutes for Medical Research | $7.91M | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS COV 2 SEROLOGICAL TESTING: 1) STANDARDIZATION; 2) ASSAY DEVELOPMENT; AND 3) AVAILABILITY OF LARGE SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN INFECTED OR EXPOSED TO… |
| 2022-11-01 | Icahn School of Medicine at Mount Sinai | $2.56M | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING: 1) STANDARDIZATION, 2) ASSAY DEVELOPMENT, AND 3) AVAILABILITY OF LARGE-SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN INFECTED OR EXPOSED TO… |
| 2022-11-01 | The Feinstein Institutes for Medical Research | $2.07M | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING: 1) STANDARDIZATION, 2) ASSAY DEVELOPMENT, AND 3) AVAILABILITY OF LARGE-SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN INFECTED OR EXPOSED TO… |
| 2024-09-12 | American Type Culture Collection | $998.9K | SAMPLE ALIQUOTING |
| 2024-03-11 | American Type Culture Collection | $832.9K | SUBCONTRACTOR SHALL PROVIDE ALIQUOTING SERVICES FOR SERONET SAMPLES ACCORDING TO STANDARD OPERATING PROCEDURES (SOPS) PROVIDED BY THE VACCINE; IMMUNITY AND CANCER DIRECTORATE (VICD) FOR SAMPLE HANDLING, RECEIPT,… |
| 2023-11-30 | Emory University | $797.3K | MS7-CHRCT & CNFRM TESTING |
| 2023-03-27 | Icahn School of Medicine at Mount Sinai | $790.9K | THE OBJECTIVE OF THE PUBLIC HEALTH INVESTIGATION IS TO DETERMINE THE ANTI-SARS-COV-2 ANTIBODY LEVELS AND SARS-COV-2 TOTAL NEUTRALIZING ANTIBODY LEVELS IN INDIVIDUAL€„¢S THAT MAY HAVE BEEN PREVIOUSLY EXPOSED TO… |
| 2023-08-24 | Essex Management LLC | $663.0K | THIS SCOPE OF WORK FOR THIS TASK ORDER IS TO PROVIDE SENIOR PROJECT MANAGEMENT SUPPORT TO ALL ACTIVITIES RELATED TO THE DEVELOPMENT OF A RWD INFRASTRUCTURE THAT WILL LEVERAGE RWD ACROSS MULTIPLE ORGANIZATIONS TO ENABLE… |
| 2024-11-13 | Essex Management LLC | $300.5K | THIS SCOPE OF WORK FOR THIS SUBCONTRACT IS TO PROVIDE SENIOR PROJECT MANAGEMENT SUPPORT TO ALL ACTIVITIES RELATED TO THE DEVELOPMENT OF A RWD INFRASTRUCTURE THAT WILL LEVERAGE RWD ACROSS MULTIPLE ORGANIZATIONS TO… |
| 2023-07-10 | Laboratory Corp of America | $294.8K | PERFORM THE FDA€Ͽ½EUA APPROVAL IMMUNOASSAYS INTENDED FOR NUCLEOCAPSID IGG QUALITATIVE AND SPIKE IGG SEMI€Ͽ½QUALITATIVE DETECTION OF ANTIBODIES TO SARSCOV€Ͽ½ 2 IN HUMAN SERUM AND PLASMA SAMPLES, AS WELL… |
| 2023-04-24 | Laboratory Corp of America | $280.0K | RECEIVE AND STORE NASAL SWAB BIOSPECIMENS FROM CESDEP AND FNLCR SEROLOGY LAB UNTIL SAMPLE PROCESSING, EXTRACT VIRAL RIBONUCLEIC ACID (RNA), AND THEN PERFORM THE QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR) ASSAY TO… |
| 2023-09-12 | Hamilton Company | $237.9K | PURCHASE OF CAPITAL EQUIPMENT/LIQUID HANDLING |
| 2025-01-10 | Information Management Services, Inc. | $225.0K | SUBCONTRACTOR WILL UPDATE AND MODIFY THE SEER RESEARCH PLUS DATASET TO REPLACE CURRENT SEER DATA IN THE COVID-19 REAL-WORLD DATA INFRASTRUCTURE (CRWDI) TO ENABLE COMPREHENSIVE ANALYSIS OF CANCER RISKS ASSOCIATED WITH… |
| 2024-10-11 | Fisher Scientific Company L.L.C. | $208.6K | LABORATORY SUPPLY AND BIOTECH COMPANY THAT PROVIDE PRODUCTS AND SERVICES. |
| 2023-08-29 | American Type Culture Collection | $192.8K | SUBCONTRACTOR SHALL PROVIDE ALIQUOTING SERVICES FOR SERONET SAMPLES ACCORDING TO STANDARD OPERATING PROCEDURES (SOPS) PROVIDED BY THE VACCINE, IMMUNITY AND CANCER DIRECTORATE (VICD) FOR SAMPLE HANDLING, RECEIPT,… |
| 2023-08-07 | American Type Culture Collection | $151.2K | SUBCONTRACTOR SHALL SUPPLY ALIQUOTING SERVICES FOR CESDEP REFERENCE AND LONGITUDINAL STUDIES. |
| 2023-09-28 | Information Management Services, Inc. | $68.2K | PROVIDE VICD WITH STATISTICAL SUPPORT FOR SAMPLE SELECTION AND TEST DATA ANALYSIS ON DATA FROM THE SERONET AND/OR CESDEP PROJECTS. |
| 2023-11-02 | Information Management Services, Inc. | $58.4K | PROVIDE VICD WITH STATISTICAL SUPPORT FOR SAMPLE SELECTION AND TEST DATA ANALYSIS ON DATA FROM THE CESDEP PROJECT |
| 2025-02-14 | Government Scientific Source Inc | $38.5K | 1 EACH OF PART # 6031 VIAFLO 384 BASE UNIT, 1 EACH PART # 6230 THREE POSITION STAGE, 1 EACH PART # 6132, 384-CHANNEL PIPETTING HEAD 5-125UL, 1 EACH PART # 999111, INSTALLATION AND TRAINING VIAFLO 384 |